Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary

Kathleen Moore, Domenica Lorusso, Ana Oaknin, Amit M. Oza, Nicoletta Colombo, Toon Van Gorp, David M. O’Malley, Susana Banerjee, Conleth G. Murphy, Philipp Harter, Gottfried E. Konecny, Patricia Pautier, Michael Method, Yuemei Wang, Robert L. Coleman, Michael Birrer, Ursula A. Matulonis